Irs1 Mouse shRNA Plasmid (Locus ID 16367)
CAT#: TF516309
Irs1 - Mouse, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (1)
Specifications
Product Data | |
Product Name | Irs1 Mouse shRNA Plasmid (Locus ID 16367) |
Locus ID | 16367 |
UniProt ID | P35569 |
Synonyms | G972R; IRS-1 |
Vector | pRFP-C-RS |
Format | Retroviral plasmids |
Kit Components | Irs1 - Mouse, 4 unique 29mer shRNA constructs in retroviral RFP vector(Gene ID = 16367). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRFP-C-RS Vector, TR30015, included for free. |
RefSeq | NM_010570, NM_010570.1, NM_010570.2, NM_010570.3, NM_010570.4, BC034138, BC156076, BC157089 |
Summary | May mediate the control of various cellular processes by insulin. When phosphorylated by the insulin receptor binds specifically to various cellular proteins containing SH2 domains such as phosphatidylinositol 3-kinase p85 subunit or GRB2. Activates phosphatidylinositol 3-kinase when bound to the regulatory p85 subunit (By similarity).[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells
,Contaldo, C;Myers, TJ;Zucchini, C;Manara, MC;Chiodoni, C;Colombo, MP;Nicoletti, G;Lollini, PL;Li, T;Longobardi, L;Scotlandi, K;Spagnoli, A;,
Growth Factors, Jan 2014.
,PubMed ID 24438070
[IRS1]
|
Mesenchymal Stem Cells Expressing Insulin-like Growth Factor-I (MSCIGF) Promote Fracture Healing and Restore New Bone Formation in Irs1 Knock-out Mice: Analyses of MSCIGF Autocrine and Paracrine Regenerative Effects
,null,
Stem cells (Dayton, Ohio)
,PubMed ID 21786367
[Irs1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...